ArticleGlobal & regional health technology assessment

Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview.

Rosario CultreraPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.